S. Shimodamatsubayashi et al., MN SOD ACTIVITY AND PROTEIN IN A PATIENT WITH CHROMOSOME 6-LINKED AUTOSOMAL RECESSIVE PARKINSONISM IN COMPARISON WITH PARKINSONS-DISEASE AND CONTROL, Neurology, 49(5), 1997, pp. 1257-1262
We report Mn superoxide dismutase (SOD) protein and activity in a pati
ent with familial autosomal recessive Lewy body-negative parkinsonism
in comparison with patients with sporadic Parkinson's disease (PD) and
controls. We recently proved linkage of this family with markers of c
hromosome 6 at 6q25.2-27, which included the Mn SOD gene. We used a no
vel polymorphic mutation at -9 position of the signal peptide of the M
n SOD precursor protein, which caused valine to alanine substitution.
All the affected members of this family showed homozygosity for alanin
e, whereas nonaffected members, sporadic PD patients, and the control
subjects studied showed either heterozygosity of alanine and valine or
homozygosity of valine. The Mn SOD activity of this familial patient
was the highest among the PD patients and the control subjects studied
, and an abundant expression of Mn SOD was found in the substantia nig
ra. The molecular weight of Mn SOD protein by Western blotting of this
patient was essentially similar to that of PD patients and the contro
l subjects. High Mn SOD activity may constitute a genetic risk factor
in this familial patient. The difference in the signal peptide sequenc
e may affect the expression of Mn SOD within mitochondria; however, it
is unlikely that loss of function type Mn SOD mutation is the cause o
f this familial parkinsonism. Mn SOD in sporadic PD patients was simil
ar to that in controls.